Mohamed Fawzy

🌟 Proud Moment for Localized Healthcare in Saudi Arabia! 🌟 I’m excited to share a significant step forward in advancing healthcare in the Kingdom. Sudair Pharmaceutical Company, in collaboration with Sanofi & National Unified Procurement Company "NUPCO" is making strides towards localizing #Insulin production in Saudi Arabia. This initiative isn’t just about meeting the growing demand for insulin in the region but about creating a robust, sustainable supply chain that caters to our unique healthcare landscape. By fostering local production, we aim to: • Ensure reliable access to life-saving insulin for patients across the Kingdom. • Reduce dependency on international supply chains. • Support national goals outlined in Saudi Vision 2030 to enhance self-sufficiency and localize essential industries. This collaboration is a testament to our shared commitment to empowering healthcare, uplifting our economy, and, most importantly, serving the people of Saudi Arabia. Stay tuned as we continue to make healthcare history together! 💪🌍 #Insulin #SaudiVision2030 #SudairPharma #Sanofi

٣١٨

١٠ تعليق

Exciting developments are underway in the biotechnology landscape of Saudi Arabia 🌍✨ , aligned with Vision 2030 and the bold initiatives set forth by HRH Crown Prince Mohammed bin Salman. At SVAX, we are dedicated to advancing the localization of biologics, biosimilars, and vaccines within our Kingdom. This strategic move is crucial for achieving national health security and reducing our reliance on imported pharmaceuticals. By strengthening our local manufacturing capabilities, we can ensure a reliable supply of high-quality treatments that address the specific needs of our population. Our vision extends beyond manufacturing; we aim to create robust collaborations with multinational pharmaceutical companies. By serving as a CMO, we can facilitate knowledge transfer, empower our local workforce, and optimize our production capabilities. Additionally, through strategic license agreements, we can further localize innovative products, making them more accessible and affordable for all. Together, we can build a sustainable biotechnology ecosystem that supports the health and wellbeing of our communities while fostering economic growth and stability. Let’s embrace this opportunity to shape the future of healthcare in Saudi Arabia! #SaudiVision2030 #Biotechnology #LocalManufacturing #HealthSecurity #SVAX #Innovation #Biologics #Biosimilars #Pharmaceuticals #KnowledgeTransfer #SustainableDevelopment

٣٨

٣ تعليق

King Faisal Specialist Hospital and Research Center (KFSHRC) Drives Saudi Arabia’s Biotechnology Leadership #KFSHRC is at the forefront of #SaudiArabia's biotech ambitions, achieving major breakthroughs in #Genomics,Biomanufacturing, and sustainable healthcare. A key milestone is the localization of CAR T-cell production, cutting treatment costs by 80% and speeding access to life-saving therapies. The hospital’s #Genomics Centre is advancing #PrecisionMedicine with #PersonalizedTreatments, and its researchers have developed Saudi Arabia’s first genetically engineered mice using #CRISPR technology. KFSHRC’s leadership in biotech is bolstered by education and training programs in genomics, #RegenerativeMedicine, and #Bioinformatics, helping to foster local expertise and solidify Saudi Arabia's position as a biotech hub. Recognized as the top academic medical center in the #MiddleEast and #Africa, KFSHRC is setting new global standards in #HealthcareInnovation. #HealthcareLeadership #MedicalInnovation #SaudiBiotech #LifeSciences #GlobalHealthcare #Biotech #RASLifeScienceSolutions #Genomics #CancerCare #PrecisionMedicine #AI #RASLifeScienceSolutions #MarketIntelligence #MarketResearch #CompetitiveIntelligence #StrategySupport #PortfolioOptimization Follow our page for more industry updates: https://lnkd.in/de5zNWmK

٢

Get ready to dive deeper! Our "Know Your Market" (KYM) series is still going strong, this time covering Kuwait. We unveiled valuable insights into the pharmaceutical market, but that's just the tip of the iceberg! Stay tuned for industry-specific breakdowns across various regions. Don't forget to check out our previous KYM episodes!

٣

If you are attending lets arrange to meet!! Connect using the app!! We can discuss Sustainability Scope 3.... Pharma or Biotech manufacturing. Sterility Assurance! How to implement criticality focussed manufacturing!!

٢

🚀 Unlocking New Synergies in Pharma: COE & GCC Markets 🚀 At Turacoz Group, we’re committed to driving innovation and excellence in the pharmaceutical industry by offering strategic collaborations tailored to the needs of Centers of Excellence (COE) and the GCC pharmaceutical market. 💡 Together, we can: Elevate patient outcomes through real-world evidence (RWE) and AI-driven insights Drive clinical success with systematic literature reviews (SLR) and narrative review articles to support decision-making Accelerate market access with HEOR (Health Economics and Outcomes Research) to showcase product value and cost-effectiveness Enhance compliance with PMCF and CER submissions for regulatory approvals Leverage digital adboards and advisory boards to engage top KOLs and HCPs Support telehealth solutions and remote patient monitoring to improve care delivery Let’s collaborate and create impactful solutions that address today’s challenges in pharma. Ready to explore how we can work together? Let’s connect! 🤝 #Pharma #COE #GCC #Turacoz #SLR #NarrativeReview #HEOR #PharmaInnovation #MedCom #PatientOutcomes #HealthcareCollaboration #Telehealth

٣

In a world where remote work is evolving, leading global teams is becoming the new norm. Here's an insightful interview between two great leaders, sharing their thoughts and offering valuable tips on managing an international team. #leadingaglobalteam #JNJ #peopleleader

٥

Leading the future

٢

Right People, Right Place Khaled Nour El Din. A Growing Opportunity in Pharma. The Saudi Arabian pharmaceutical market is set to hit $11.5 billion by 2032, fueled by Vision 2030 reforms, increasing chronic diseases, and rising healthcare investments. Meanwhile, the MENA pharmaceutical market, valued at $42 billion in 2022, is projected to grow at a 6-7% CAGR through 2030, with Saudi Arabia playing a pivotal role due to its strong healthcare initiatives and appeal to global pharmaceutical companies. #marketentry #otipharmalliance #cphimiddleeast

٢٥

Happy to share our latest research, "Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia." 💡 This study highlights the long-term safety and effectiveness of evolocumab, offering critical insights for improving cardiovascular health outcomes. 🔗 Read the full study: https://lnkd.in/epzGSVzU. Special thanks to Dr. Abdulaali AlMutairi, PharmD, PhD, BCMAS, and all co-authors for their outstanding efforts!

٥٦

Every breath is precious, and so is your awareness. Lung cancer is a challenging disease, but with proactive measures, we can make a difference. Screening for lung cancer is a critical step in detecting the disease at an early, more treatable stage. 🔍 Early Detection Matters: Regular screenings for those at high risk can detect lung cancer before symptoms appear, improving treatment outcomes and survival rates. 👩‍⚕️ Talk to Your Doctor: If you're at high risk, such as current or former smokers, discuss screening options with your healthcare provider. They can help determine the best approach for you. 🌟 Spread Awareness: By sharing this post, you're helping to spread awareness about the importance of screening for lung cancer. Together, we can make a real impact. Let's stand together to raise awareness and emphasize the significance of early screening for lung cancer. Together, we can improve outcomes and save lives. #nafsakhayah #LungCancerAwareness Watch the below video and educate yourself:- https://lnkd.in/gSnHRgVk Nour Ali Shokry Mai Eissa Touka Mater Ahmed Kishta

٨

M&A in the MENA Pharma Market: A Complex Landscape Despite high growth potential, the MENA pharma market remains a challenging environment for M&A. Inflated valuations, deep market nuances, and government protectionism continue to hinder successful deals. While the region has seen notable acquisitions like Sanofi's purchase of UAE-based Global Pharma and Valeant's acquisition of UAE-based Medpharma in 2014, these examples also highlight the complexities involved. It's clear that a deep understanding of local dynamics and a long-term perspective are crucial for success. While PE firms remain active, the path to a profitable M&A deal is still fraught with challenges. What are your thoughts on the MENA pharma M&A landscape? Share your insights and experiences below. #MENApharma #M&A #pharmaindustry #pharmabusiness #challenges #investment #PE

٣

At AstraZeneca, we are dedicated to improving patient outcomes for lung cancer by emphasizing early detection. By identifying the disease at its earliest stages, we can implement timely and effective treatments, ultimately enhancing patient quality of life and reducing the long-term burden on healthcare systems. Our commitment to innovative research and advanced diagnostic technologies underscores our mission to transform the future of healthcare. Additionally, in #NearEast and #Maghreb we are actively involved in initiatives such as lung cancer screening via government and patient association collaborations to promote equitable access to cancer care. More into this subject and preventive measures can be found in this article by Independent Arabia https://lnkd.in/ekaXscKe #WorldLungCancerDay #LungCancer #EarlyDetection Peter Raouf Sarah Sakr Khoury Jennifer Jackson George Fouad Jinane Hajjar Amine Sekhri Ayman Rahhal Mohanad Alyas Abdulkareem Al Dissi Maria Nauss

٧٨

Updated forecast of International Monetary Fund for economic growth. 🇸🇦 Growth in 2025 leading G20 and will be the 2nd highest growth rate among the G20 countries (behind India at 6.5%) 🙌 #saudivision2030 #saudieconomy

٥

Thanks to PharmaBoardroom giving me the opportunity to share my believes about the opportunities of Pharma industry in the Kingdom of Saudi Arabia and how AbbVie is committed toward innovation, talent development and health care transformation aligned with Saudi’s vision 2030

٢٦٥

٢٥ تعليق